These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37164671)

  • 21. CK7/CK20 Double-Negative Pulmonary Enteric Adenocarcinoma With Histopathological Evaluation of Transformation Zone Between Enteric Adenocarcinoma and Conventional Pulmonary Adenocarcinoma.
    Miyaoka M; Hatanaka K; Iwazaki M; Nakamura N
    Int J Surg Pathol; 2018 Aug; 26(5):464-468. PubMed ID: 29411669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDX2-positive Cancer of Unknown Primary With Upper-body Paralysis Was Dramatically Improved by Colorectal Cancer Chemotherapy.
    Akagi H; Tanaka Y; Wada K; Takahashi M; Yoshida K; Domoto H
    Anticancer Res; 2023 Jun; 43(6):2879-2884. PubMed ID: 37247890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.
    Park SY; Kim BH; Kim JH; Lee S; Kang GH
    Arch Pathol Lab Med; 2007 Oct; 131(10):1561-7. PubMed ID: 17922593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous regression of transverse colon cancer with high-frequency microsatellite instability: a case report and literature review.
    Karakuchi N; Shimomura M; Toyota K; Hinoi T; Yamamoto H; Sadamoto S; Mandai K; Egi H; Ohdan H; Takahashi T
    World J Surg Oncol; 2019 Jan; 17(1):19. PubMed ID: 30646898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers CDX2, CK20, CK7 in Schoolchildren with Gastritis in the Realization of Familial Predisposition of Stomach Cancer.
    Polivanova TV; Kasparov EV; Vshivkov VA; Peretyatko OV
    Bull Exp Biol Med; 2021 Dec; 172(2):187-190. PubMed ID: 34853972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease.
    Perrotto J; Abbott JJ; Ceilley RI; Ahmed I
    Am J Dermatopathol; 2010 Apr; 32(2):137-43. PubMed ID: 20051815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 28. Double primary adenocarcinomas of the jejunum and descending colon with lung metastases presenting rare immunohistochemical phenotypes: a case report.
    Nozawa H; Yamada Y; Muto Y; Endo J; Asakage M; Oka T; Furukawa Y; Arai M
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):228-33. PubMed ID: 19923997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Right Hemi-Colectomy for a Metastatic Transverse Colon Tumor from Breast Cancer Following Bilateral Breast Cancer Resection - A Case Report].
    Okamura S; Yanagisawa T; Ohishi K; Murata K; Nushijima Y; Hamano R; Fukuchi N; Ebisui C; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2047-2049. PubMed ID: 28133217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of ampulla of Vater cancer subtype classification based on immunohistochemical staining.
    Kwon CH; Ahn JH; Seo HI; Kim DU; Han SY; Kim S; Lee NK; Hong SB; Park YM; Noh BG
    World J Surg Oncol; 2024 Jan; 22(1):5. PubMed ID: 38167037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.
    Vang R; Gown AM; Wu LS; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
    Mod Pathol; 2006 Nov; 19(11):1421-8. PubMed ID: 16980943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.
    Mazziotta RM; Borczuk AC; Powell CA; Mansukhani M
    Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):55-60. PubMed ID: 15722794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases].
    Fernandez C; Liprandi A; Bouvier-Labit C; Figarella-Branger D
    Ann Pathol; 2001 Apr; 21(2):129-35. PubMed ID: 11373582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2.
    Altree-Tacha D; Tyrrell J; Haas T
    Arch Pathol Lab Med; 2017 Jan; 141(1):144-150. PubMed ID: 28029907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.
    Zhu AX; Knox JJ
    Oncologist; 2012; 17(12):1504-7. PubMed ID: 23220842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas.
    Yatabe Y; Koga T; Mitsudomi T; Takahashi T
    J Pathol; 2004 Jun; 203(2):645-52. PubMed ID: 15141379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
    Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC; Su YC; Wang SL; Chai CY
    Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.